Endothelin receptors in the failing and nonfailing human heart

Circulation

Volumn 97, Issue 8, 1998, Pages 744-751

  Pönicke, Klaus ^a   Vogelsang, Magdalene ^b   Heinroth, Moritz ^a   Becker, Karin ^a   Zolk, Oliver ^c   Böhm, Michael ^c   Zerkowski, Hans Reinhard ^a   Brodde, Otto Erich ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Endothelin; Heart failure; Inositol phosphates; Receptors

Indexed keywords

ADENYLATE CYCLASE; CARBACHOL; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN RECEPTOR; FORSKOLIN; INOSITOL PHOSPHATE; ISOPRENALINE;

ARTICLE; CONGESTIVE HEART FAILURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; HEART FUNCTION; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INOTROPISM; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR BINDING; STATISTICAL ANALYSIS;

EID: 0345698727     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.8.744     Document Type: Article

References (48)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cell. Nature. 1988;332:411-415.
2. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev. 1994;46:325-415.
3. Moravec CS, Reynolds EE, Stewart RW, Bond M. Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem Biophys Res Commun. 1989;159:14-18.
4. 125I]endothelin-l in humans, pigs, and rats: functional relevance in humans. J Cardiovasc Pharmacol. 1989:13(suppl 5) :S 166-S170.
5. Moody CJ, Dashwood MR, Sykes RM, Chester M, Joncs SM. Yacoub MH, Harding SE. Functional and autoradiographic evidence for endothelin 1 receptor, on human and rat cardiac myocytes. Circ Res. 1990;67:764-769.
6. Zerkowski H-R, Broede A, Kunde K, Hillemann S, Schäfer E, Vogelsang M, Michel MC, Brodde O-E. Comparison of the positive inotropic effects of serotonin, histamine, angiotensin II, endothelin and isoprenaline in the isolated human right atrium. Nature Schmiedebergs Arch Pharmacol. 1993;347:347-352.
7. Meyer M, Lehnart S, Pieske B, Schlottauer K, Munk S, Holubanch C, Just H, Hasenfuss G. Influence of endothelin-1 on human atrial myocardium: myocardial function and subcellular pathways. Basic Res Cardiol. 1996;91:86-93.
8. Pieske B, Beyermann B, Duis J, Clozel M, Breu V. Endothelin-1 increases contractility in human dilated cardiomyopathy via an upregulared ET-A receptor subtype. Circulation. 1996;94(suppl I):I-406. Abstract.
9. Sugden PH, Bogoyevitch MA. Endothelin-1 dependent signaling pathways in the myocardium. Trends Cardivasc Med. 1996;6:87-94.
10. Masaki T, Vane JR, Vanhoutte PM. International Union of Pharmacology: nomenclature of endothelin receptors. Pharmacol Rev. 1994;46:137-142.
11. Molenaar P, O'Reilly G, Sharkey A, Kuc RE, Harding DP. Plumpton C, Gresham GA, Davenport AP. Characterization and localization of endothelin receptor subtypes in human atrioventricular conducting system and myocardium. Circ Res. 1993;72:526-538.
12. Bax WA, Bruinnvels AT, van Suylen R-J, Saxena PR, Hoyer D. Endothelin receptors in the human coronary artery, ventricle and atrium. Naunyn Schmiedebergs Arch Pharmacol. 1993;348:403-410.
13. Takigawa M. Sakurai T, Kasuya Y, Abe A. Masaki T, Goto K. Molecular identification of guanine-nucleotide-binding regulatory proteins which couple to endothelin receptors. Eur J Biochem. 1995;228:102-108.
14. Hilal-Dandebn R, Merck ST, Lujan JP, Brunton LL. Coupling of the type A endothelin receptor to multiple responses in adult rat cardiomyocytes. Mol Pharmacol, 1994;45:1183-1190.
15. A-receptors couple to inositol phosphate formation and inhibition of adenylate cyclase in human right atrium. J Cardiovasc Pharmacol. 1994;23:344-347.
16. Love MP, McMurray JJV. Endothelin in congestive hean failure. Basic Res Cardiol. 1996:91(suppl 1):21-29.
17. Cohn JN. Is there a role for endothelin in the natural history of heart failure? Circulation. 1996,94:604-606.
18. Kiowski W, Sutsch G, Hunziker P, Müller P, Kim J, Oechslin E, Schmitt R, Jones R, Bertel O. Evidence of endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet, 1995;346:732-736.
19. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature. 1996;384:353-355.
20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem. 1976;72:248-254.
21. Becker K, Erdbrügger W, Heinroth-Hoffmann I, Michel MC, Brodde O-E. Endothelin-induced inositol phosphate formation in rat kidney: studies on receptor subtypes. G-proteins and regulation during ontogenesis. Nauny Schmiedebergs Arch Pharmacol. 1996;354:572-578.
22. Clozel M, Breu V, Gray GA, Kalina B, Löftier BM, Burri K, Cassal J-M, Hirth G, Müller M. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther, 1994;270:228-235.
23. A receptor antagonist. Cardiovasc Drug Rev. 1994;12:48-69.
24. Brodde O-E, Zerkowski H-R, Schranz D, Broede-Sitz A, Michel-Reher M. Schäfer-Beisenbusch E, Piotrowski JA, Oelert H. Age-dependent changes of the β-adrenoceptor-G-protein(s)-adenylycyclase system in human right atrium. J Cardiovasc Pharmacol. 1995;26:20-26.
25. Salomon Y, Londos C, Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 1974;58:541-548.
26. Michel MC, Brodde O-E, Insel PA. Are cardiac G-proteins altered in rat models of hypertension? J Hypertens. 1993;11:353-363.
27. 50) of an enzymatic reaction. Biochem Pharmacol. 1973;22:3099-3108.
28. Hemsen A, Franco-Cereceda A, Matran R, Rudehill A, Lundberg JM, Occurrence, specific binding sites and functional effects of endothelin in human cardiopulmonary tissue. Eur J Pharmacol. 1990;191:319-328.
29. B sub-types in cardiac ventricle and rat cerebellum. Br J Pharmacol. 1992;107(suppl):304. Abstract.
30. A receptors in the heart. Br J Pharmacol. 1995;114:297-302.
31. Pönicke K, Heinroth-Hoffmann I, Decker K, Brodde O-E. Trophic effect of angiotensin II in neonatal rat cardiomyocytes: role of endothelin-1 and non-myocyte cells. Br J Pharmacol, 1997;121:118-124.
32. Shubeita HE, McDonough PM, Harris AN, Knowlton KU, Glembotzki CC, Brown JH, Chien KR. Endothelin-induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes: A paracrine mechanism for myocardial cell hypertrophy. J Biol Chem. 1990;265:20555-20562.
33. Jones LG, Gause KC, Meier KE. Effects of endothelin on mitogen-activated protein kinase activity and protein synthesis in isolated feline cardiac myocytes. Life Sci. 1996:58:617-630.
34. Brodde O-E. Michel MC, Zerkowski H-R, Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure. Cardiovasc. Res. 1995;30:570-584.
35. Böhm M. Alterations of β-adrenoceptor-G-protein-regulated adenylyl cyclase in heart failure. Mol Cell Biochem. 1995;147:147-160.
36. Bristow MR. Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol. 1993;22(suppl 4):61A-71A.
37. A receptor mRNA and increases responsiveness to endothelin-1 of rat aortic smooth muscle cells in primary culture. Biochem Biophys Res Commun. 1992;188:719-726.
38. 1-adrenoceptor mRNA levels. J Biol Chem. 1991;266:2233-2238.
39. Fujisaki H, Ito H, Hirata Y, Tanaka M, Hata M, Lin M, Adachi S, Akimoto H, Marumo F, Hiroe M. Natriuretic peprides inhibir angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-l gene expression. J Clin Invest. 1995;96:1059-1065.
40. Regitz-Zajrrosek V. Friedel N, Heymann A. Bauer P, Neuβ M, Rolfs A, Steffen C, Hildebrandt A, Hetzer R, Fleck E. Regulation, chamber localization, and subtype distribution of angiounsin II receptors in human heart. Circulation. 1995;91:1461-1471.
41. Asano K, Dutcher DL, Port D, Minobe WA, Tremmel KD. Roden RL, Bohlmeyer TJ, Bush EW, Jenkin MJ, Abrahan WT, Raynolds MV, Zisman LS, Ferryman MB, Bristow MR. Selective downregulation of the angiotensin II AT,-receptor subtype in tailing human ventricular myocardium. Circulation. 1997;95:1193-1200
42. 2: angiotensin receptor gene expression in human heart failure. Circulation. 1997;95:1201-1206.
43. Viliareal FJ, Kim NN, Ungab GD, Printz MP. Dillmann WH. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation. 1993;88:2849-2861.
44. Kim NN, Villareal FJ. Printz MP, Lee AA, Dillmann WH. Trophic effects of angiotensin II on neonatal rat cardiomyocytes are mediated by cardiac fibroblasts. Am J Physiol. 1995;269:E426-E437.
45. Regitz-Zagrosek V, Neuβ M, Warnecke C, Holzmeister J, Hildebrandt A, Fleck E. Subtype 2 and atypical angiotensin receptors in the human heart. Basic Res Cardiol. 1997;91(Suppl 2):73-77.
46. Feldman AM. Modulation of adrenergic receptors and G-transduction proteins in failing human ventricular myocardium. Circulation. 1993;87(suppl IV):IV-27-IV-34.
47. Schnabel P, Böhm M. Heterotrimeric G proteins in heart disease. Cell Signal. 1996;8:413-423.
48. Sugden PH, Bogoyevitch MA. Intracellular signalling through protein kinases in the heart. Cardiovasc Res. 1995;30:478-492.